2018

1. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

   Biochemical Pharmacology, Vol. 157, pp. 189-201

2. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis

   Neuropharmacology, Vol. 141, pp. 181-191